Alutard Sq

Alutard SQ is a subcutaneous allergy immunotherapy treatment designed to reduce sensitivity to dust mites. It contains extracts of Dermatophagoides farinae and Dermatophagoides pteronyssinus, formulated with aluminum. This product is manufactured by Alk-Abello A/S in the EU.

Alutard SQ is primarily used for the treatment of allergies caused by dust mites. It works by gradually reducing the body's sensitivity to these allergens, potentially alleviating symptoms such as sneezing, itching, and nasal congestion. This therapy is often considered for individuals who experience persistent allergic reactions to dust mites.

Common effects of Alutard SQ may include localized reactions at the injection site, such as redness, swelling, or itching. Some individuals might experience temporary systemic reactions like mild fatigue or headache. These effects are generally mild and transient, but any severe or persistent symptoms should be discussed with a healthcare provider.

Alutard SQ should be administered under the supervision of a healthcare professional. Individuals with a history of severe allergic reactions or asthma should use this product with caution. It is important to follow the prescribed dosage and administration schedule to minimize the risk of adverse effects.

Alutard SQ may interact with other medications, particularly those that affect the immune system. It is advisable to inform your healthcare provider about all medications you are taking before starting this therapy. Additionally, alcohol and certain supplements might influence the effectiveness or safety of Alutard SQ.